US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Redhill Biopharma Ltd. - American Depositary Shares
(NQ:
RDHL
)
0.5000
+0.0200 (+4.17%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Redhill Biopharma Ltd. - American Depositary Shares
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
24 Stocks Moving in Tuesday's Pre-Market Session
↗
June 21, 2022
Gainers Valneva SE (NASDAQ: VALN) shares rose 83.6% to $25.18 in pre-market trading following Pfizer agreement to acquire an 8.1% stake.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
May 11, 2022
On Wednesday, 807 companies reached new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
May 09, 2022
Via
Benzinga
26 Stocks Moving in Thursday's Pre-Market Session
↗
April 21, 2022
Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday. Clarus Therapeutics Holdings, Inc. (NASDAQ:...
Via
Benzinga
RedHill Biopharma Says Opaganib Can Potentially Work Against COVID-19 Omicron Subvariants
↗
April 11, 2022
Via
Benzinga
RedHill, Kukbo Ink Oral Opaganib Licensing Pact For COVID-19 In South Korea
↗
March 15, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
May 04, 2022
During Wednesday's trading, 435 companies set new 52-week lows.
Via
Benzinga
RedHill Biopharma Ltd Announces Potent Omicron Inhibition with RedHill's Opaganib
April 11, 2022
Oral opaganib's reported potent in vitro activity against Omicron adds to previously observed inhibition of Delta and other SARS-CoV-2 variants of concern that cause COVID-19; Testing conducted by The...
From
RedHill Biopharma Ltd
Via
AccessWire
64 Biggest Movers From Yesterday
↗
March 18, 2022
Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:...
Via
Benzinga
Redhill Biopharma: Q4 Earnings Insights
↗
March 17, 2022
Redhill Biopharma (NASDAQ:RDHL) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Earnings Scheduled For March 17, 2022
↗
March 17, 2022
Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is...
Via
Benzinga
Redhill Biopharma's Earnings: A Preview
↗
March 16, 2022
Redhill Biopharma (NASDAQ:RDHL) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
RedHill Biopharma's Upamostat Shows 100% Efficacy In Non-Hospitalized COVID-19 Patients
↗
March 01, 2022
RedHill Biopharma Ltd (NASDAQ: RDHL) has announced topline results from the Phase 2 part of the Phase 2/3 study of RHB-107 (upamostat) in non-hospitalized...
Via
Benzinga
RedHill Biopharma's COVID-19 Antiviral Cuts Mortality By 70% In Remdesivir Treated Patients
↗
February 07, 2022
RedHill Biopharma Ltd (NASDAQ: RDHL) has announced results from two recently completed prespecified analyses from the oral opaganib Phase 2/3 study in hospitalized severe COVID-19.
Via
Benzinga
18 Stocks Moving in Friday's Pre-Market Session
↗
January 14, 2022
Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) shares rose 17.6% to $0.8350 in pre-market trading after dropping around 9% on Thursday. NextPlay Technologies, Inc...
Via
Benzinga
RedHill Biopharma's Oral COVID-19 Treatment Improves Median Time To Viral RNA Clearance
↗
January 13, 2022
RedHill Biopharma Ltd (NASDAQ: RDHL) announced new data from a prespecified analysis of all oral opaganib's Phase 2/3 study patients in COVID-19 patients. The...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
March 15, 2022
During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by...
Via
Benzinga
63 Biggest Movers From Yesterday
↗
December 31, 2021
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
December 30, 2021
Gainers Kiora Pharmaceuticals (NASDAQ:KPRX
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
↗
December 30, 2021
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 52.3% to $1.3396. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors. Future...
Via
Benzinga
RedHill Announces Additional Insider Buying
December 15, 2021
RALEIGH, NC and TEL-AVIV, ISRAEL / ACCESSWIRE / December 15, 2021 / RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that...
From
RedHill Biopharma Ltd
Via
AccessWire
Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday
↗
December 14, 2021
Photo by Chris Montgomery on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
RedHill Biopharma's Talicia Recommended For H. Pylori Infection
↗
December 09, 2021
RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study revealing concerning rates of widespread, physician-directed prescribing of...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
December 09, 2021
Good morning, trader! It's time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori
December 09, 2021
RedHill Biopharma: Concerning Rates of Clarithromycin Prescribing for H. pylori, Despite Increasing Antibiotic Resistance, Uncovered in New Digestive Diseases & Sciences Publication Despite increasing...
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
RedHill Biopharma Says Opaganib Mechanism Against COVID-19 Not Impacted By Omicron Mutations
↗
December 06, 2021
RedHill Biopharma Ltd (NASDAQ: RDHL) announced that opaganib's proposed mechanism of action is not impacted by spike protein mutations. Opaganib is expected to be...
Via
Benzinga
Anxious World Waits As Covid Vaccine Makers Address Omicron Variant
December 07, 2021
Palm Beach, FL – December 7, 2021 – FinancialNewsMedia.com News Commentary There are many unknowns surrounding the new omicron Covid variant; there are early signs it’s more transmissible, but it’s not...
Via
FinancialNewsMedia
RedHill Biopharma Ltd - Opaganib MoA Not Impacted by Omicron Mutations
December 06, 2021
Unique Mode of Action Opaganib works by targeting the human host cell rather than the virus itself and is therefore not expected to be impacted by spike protein mutations, providing a strong rationale...
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
RedHill Biopharma's Talicia For Bacterial Infections Shows Efficacy Irrespective of Patient BMI
↗
December 02, 2021
RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study of Talicia to treat H. pylori infection. The new publication, describing a ...
Via
Benzinga
RedHill Biopharma Ltd Announces Talicia: Consistent Efficacy Irrespective of BMI
December 02, 2021
RedHill Biopharma Data Published in GastroHep Shows Consistent Efficacy of Talicia Irrespective of Patient BMI High Body Mass Index and obesity are known risk factors for H. Pylori eradication...
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
